首页> 外文期刊>Health policy and planning. >What is the out-of-pocket expenditure on medicines in India? An empirical assessment using a novel methodology
【24h】

What is the out-of-pocket expenditure on medicines in India? An empirical assessment using a novel methodology

机译:印度的药品自付费用是多少?使用新方法的实证评估

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The share of expenditure on medicines as part of the total out-of-pocket (OOP) expenditure on healthcare services has been reported to be much higher in India than in other countries. This study was conducted to ascertain the extent of this share of medicine expenditure using a novel methodology. OOP expenditure data were collected through exit interviews with 5252 out-patient department patients in three states of India. Follow-up interviews were conducted after Days 1 and 15 of the baseline to identify any additional expenditure incurred. In addition, medicine prescription data were collected from the patients through prescription audits. Self-reported expenditure on medicines was compared with the amount imputed using local market prices based on prescription data. The results were also compared with the mean expenditure on medicines per spell of ailment among non-hospitalized cases from the National Sample Survey (NSS) 75th round for the corresponding states and districts, which is based on household survey methodology. The share of medicines in OOP expenditure did not change significantly for organized private hospitals using the patient-reported vs imputation-based methods (30.74-29.61). Large reductions were observed for single-doctor clinics, especially in the case of 'Ayurvedic' (64.51-36.51) and homeopathic (57.53-42.74) practitioners. After adjustment for socio-demographic factors and types of ailments, we found that household data collection as per NSS methodology leads to an increase of 25 and 26 in the reported share of medicines for public- and private-sector out-patient consultations respectively, as compared with facility-based exit interviews with the imputation of expenditure for medicines as per actual quantity and price data. The nature of healthcare transactions at single-doctor clinics in rural India leads to an over-reporting of expenditure on medicines by patients. While household surveys are valid to provide total expenditure, these are less likely to correctly estimate the share of medicine expenditure.
机译:据报道,印度的药品支出占医疗保健服务自付费用总额的比例远高于其他国家。本研究旨在使用一种新方法确定这一药物支出份额的程度。OOP 支出数据是通过对印度三个邦的 5252 名门诊部患者的离职访谈收集的。在基线的第 1 天和第 15 天之后进行后续访谈,以确定发生的任何额外支出。此外,还通过处方审核从患者那里收集药物处方数据。将自我报告的药品支出与根据处方数据使用当地市场价格估算的金额进行了比较。该结果还与基于家庭调查方法的全国抽样调查(NSS)第75轮中相应州和地区的非住院病例每次患病的平均药物支出进行了比较。对于使用患者报告方法与基于归因方法的有组织的私立医院,药物在OOP支出中的份额没有显着变化(30.74-29.61%)。单医生诊所的病例大幅减少,尤其是“阿育吠陀”(64.51-36.51%)和顺势疗法(57.53-42.74%)从业者。在对社会人口因素和疾病类型进行调整后,我们发现,根据NSS方法收集家庭数据,与基于设施的退出访谈相比,公共和私营部门门诊咨询的报告药物份额分别增加了25%和26%,并根据实际数量和价格数据进行药物支出估算。印度农村地区单一医生诊所的医疗保健交易的性质导致患者过度报告药品支出。虽然住户调查可以有效地提供总支出,但这些调查不太可能正确估计医药支出的份额。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号